REQUEST A DEMO
Total
USD $0.00
Search more companies

Indrayani Biotech Ltd. (India)

Main Activities: Travel Arrangement and Reservation Services
Full name: Indrayani Biotech Ltd. Profile Updated: April 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Indrayani Biotech Limited (IBL) is a company located in Chennai, Tamil Nadu, India. It was incorporated on March 9, 1992, and became a public limited company on March 13, 1992. The company operates in various sectors including Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture, and Infrastructure. Each of these sectors is managed by entrepreneurs with expertise in their respective fields. In 2018, Mr. Kasiraman Sayee Sundar acquired a majority stake in the company and became a director. The registered office of the company was moved to Chennai. In 2019, a scheme of amalgamation was approved, merging A-Diet Hospitality Service Limited and Helios Solutions Limited with Indrayani Biotech Limited. The scheme was approved by the National Company Law Tribunal (NCLT) in Chennai in 2020. IBL has subsidiaries such as IBL Healthcare Private Limited, Dindigul Farm Products Private Limited, Matrix Boilers Private Limited, IBL Investments Limited, IBL Social Foundation, HSL Agri Solutions Private Limited, and Healthway India Private Limited. The company also acquired KNISS Laboratories Private Limited and has acquired equity in M/S Peekay Mediequip Limited and M/S Vaasan Medical (India) Private Limited. IBL follows a business model where each business unit is professionally managed by independent teams of experts. The company supports its business units through strong corporate functions and central policies. The registered and corporate office of Indrayani Biotech Limited is located in Chennai, at Module# 32, 33, Block-1, SIDCO Electronics Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai - 600 032, Tamil Nadu, India. The company can be contacted via email at info@indrayani.com or by phone at +91-44-22502146 and +91-44-24463751. The working hours are Monday to Saturday, from 9AM to 5PM.

Legal Address
Module No. 32-33, Block-1, SIDCO Electronics Complex, Thiru-vi-ka, Guindy,
Chennai; Tamil Nadu; Postal Code: 600032

Contact Details: Purchase the Indrayani Biotech Ltd. report to view the information.

Website: http://www.indrayani.com

Basic Information
Total Employees:
Purchase the Indrayani Biotech Ltd. report to view the information.
Outstanding Shares:
Purchase the Indrayani Biotech Ltd. report to view the information.
Registered Capital:
Purchase the Indrayani Biotech Ltd. report to view the information.
Financial Auditors:
Purchase the Indrayani Biotech Ltd. report to view the information.
Incorporation Date:
March 09, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
44.33%
Purchase this report to view the information.
42.13%
Purchase this report to view the information.
8.47%
Purchase this report to view the information.
5.07%
Purchase this report to view the information.
Subsidiaries
RoomsXML Solutions Ltd.
100%
Company Performance
Financial values in the chart are available after Indrayani Biotech Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
174.87%
Total operating revenue
174.87%
Operating profit (EBIT)
157.53%
EBITDA
192.94%
Net Profit (Loss) for the Period
121.28%
Total equity
33.04%
Operating Profit Margin (ROS)
-0.58%
Net Profit Margin
-1.24%
Return on Equity (ROE)
5.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?